Citius Pharmaceuticals, Inc. Common Stock (CTXR)
Across 19 earnings reports since Aug 12, 2021, Citius Pharmaceuticals, Inc. Common Stock (CTXR) has a clear post-earnings pattern. It moves ±9.61% on average after reporting and finishes higher 15.8% of the time. Its largest post-earnings gain was +9.09% (Dec 27, 2024) and its largest decline was -26.21% (Aug 14, 2026). The next earnings report is predicted for 2026-12-25 (estimated).
Earnings reactions
How CTXR moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±9.61%
Positive %
15.8%
Negative %
84.2%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 14, 2026 | ☽ POST | -26.21% | open_in_new |
| May 15, 2026 | ☽ POST | -25.22% | open_in_new |
| Feb 13, 2026 | ☀ PRE | -4.58% | open_in_new |
| Dec 23, 2025 | ☽ POST | -22.93% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±9.61%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260821 | open_in_new SEC.gov |
| 10-Q | 20260814 | open_in_new SEC.gov |
| 8-K | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| UPLOAD | 20260810 | open_in_new SEC.gov |
| 8-K | 20260805 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260604 | open_in_new SEC.gov |
| EFFECT | 20260602 | open_in_new SEC.gov |
| 8-K | 20260601 | open_in_new SEC.gov |
| CORRESP | 20260529 | open_in_new SEC.gov |
Frequently asked about CTXR earnings
When does Citius Pharmaceuticals, Inc. Common Stock report earnings next? expand_more
Citius Pharmaceuticals, Inc. Common Stock (CTXR)'s next earnings date is estimated for 2026-12-25. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CTXR stock move after earnings? expand_more
Over 19 reports, CTXR has moved an average of ±9.61% the session after earnings, closing higher 15.8% of the time.
What was CTXR's biggest post-earnings move? expand_more
CTXR's largest post-earnings gain on record was +9.09% on Dec 27, 2024, and its largest decline was -26.21% on Aug 14, 2026.
Where can I find Citius Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more
All of Citius Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right